NanoRepro AG (ETR:NN6)
Germany · Delayed Price · Currency is EUR 1.630
-0.025 (-1.51%)
Nov 6, 2025, 5:36 PM CET
NanoRepro AG Revenue
NanoRepro AG had revenue of 2.74M EUR in the half year ending December 31, 2024, a decrease of -78.68%. This brings the company's revenue in the last twelve months to 5.22M, up 42.77% year-over-year. In the year 2024, NanoRepro AG had annual revenue of 4.51M with 41.68% growth.
Revenue (ttm)
5.22M
Revenue Growth
+42.77%
P/S Ratio
4.00
Revenue / Employee
226.86K
Employees
23
Market Cap
20.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.51M | 1.33M | 41.68% |
| Dec 31, 2023 | 3.18M | -35.61M | -91.79% |
| Dec 31, 2022 | 38.79M | -124.00M | -76.17% |
| Dec 31, 2021 | 162.79M | 145.86M | 861.58% |
| Dec 31, 2020 | 16.93M | 15.12M | 837.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.28B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.52B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.40B |